vs

Side-by-side financial comparison of MP Materials Corp. (MP) and Xeris Biopharma Holdings, Inc. (XERS). Click either name above to swap in a different company.

MP Materials Corp. is the larger business by last-quarter revenue ($90.6M vs $85.8M, roughly 1.1× Xeris Biopharma Holdings, Inc.). Xeris Biopharma Holdings, Inc. runs the higher net margin — 12.9% vs -8.8%, a 21.7% gap on every dollar of revenue. On growth, MP Materials Corp. posted the faster year-over-year revenue change (49.1% vs 42.8%). Over the past eight quarters, MP Materials Corp.'s revenue compounded faster (70.3% CAGR vs 45.3%).

MP Materials Corp. is a U.S.-based producer of rare earth materials. The company owns and operates the Mountain Pass mine in California, the only active rare earth mining and processing facility in the Western Hemisphere, producing essential materials for electric vehicles, wind turbines, and defense applications.

Xeris Biopharma Holdings, Inc. is a specialty biopharmaceutical company that develops and commercializes targeted therapies for rare endocrine, metabolic, and dermatological conditions. It operates across global markets, focusing on delivering accessible, easy-to-administer treatment options for underserved patient segments.

MP vs XERS — Head-to-Head

Bigger by revenue
MP
MP
1.1× larger
MP
$90.6M
$85.8M
XERS
Growing faster (revenue YoY)
MP
MP
+6.3% gap
MP
49.1%
42.8%
XERS
Higher net margin
XERS
XERS
21.7% more per $
XERS
12.9%
-8.8%
MP
Faster 2-yr revenue CAGR
MP
MP
Annualised
MP
70.3%
45.3%
XERS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
MP
MP
XERS
XERS
Revenue
$90.6M
$85.8M
Net Profit
$-8.0M
$11.1M
Gross Margin
Operating Margin
19.5%
Net Margin
-8.8%
12.9%
Revenue YoY
49.1%
42.8%
Net Profit YoY
64.8%
316.7%
EPS (diluted)
$-0.04
$0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MP
MP
XERS
XERS
Q1 26
$90.6M
Q4 25
$52.7M
$85.8M
Q3 25
$53.6M
$74.4M
Q2 25
$57.4M
$71.5M
Q1 25
$60.8M
$60.1M
Q4 24
$61.0M
$60.1M
Q3 24
$62.9M
$54.3M
Q2 24
$31.3M
$48.1M
Net Profit
MP
MP
XERS
XERS
Q1 26
$-8.0M
Q4 25
$9.4M
$11.1M
Q3 25
$-41.8M
$621.0K
Q2 25
$-30.9M
$-1.9M
Q1 25
$-22.6M
$-9.2M
Q4 24
$-22.3M
$-5.1M
Q3 24
$-25.5M
$-15.7M
Q2 24
$-34.1M
$-15.0M
Operating Margin
MP
MP
XERS
XERS
Q1 26
Q4 25
-7.0%
19.5%
Q3 25
-125.2%
9.0%
Q2 25
-76.5%
6.3%
Q1 25
-57.2%
-5.1%
Q4 24
-72.1%
2.8%
Q3 24
-62.8%
-23.8%
Q2 24
-171.1%
-17.0%
Net Margin
MP
MP
XERS
XERS
Q1 26
-8.8%
Q4 25
17.9%
12.9%
Q3 25
-78.0%
0.8%
Q2 25
-53.8%
-2.7%
Q1 25
-37.2%
-15.3%
Q4 24
-36.6%
-8.5%
Q3 24
-40.5%
-29.0%
Q2 24
-108.9%
-31.2%
EPS (diluted)
MP
MP
XERS
XERS
Q1 26
$-0.04
Q4 25
$0.07
$0.07
Q3 25
$-0.24
$0.00
Q2 25
$-0.19
$-0.01
Q1 25
$-0.14
$-0.06
Q4 24
$-0.12
$-0.02
Q3 24
$-0.16
$-0.11
Q2 24
$-0.21
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MP
MP
XERS
XERS
Cash + ST InvestmentsLiquidity on hand
$1.7B
$111.0M
Total DebtLower is stronger
$1.0B
$220.3M
Stockholders' EquityBook value
$2.0B
$13.7M
Total Assets
$3.8B
$383.5M
Debt / EquityLower = less leverage
0.51×
16.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MP
MP
XERS
XERS
Q1 26
$1.7B
Q4 25
$1.2B
$111.0M
Q3 25
$1.1B
$91.6M
Q2 25
$261.5M
$59.3M
Q1 25
$198.3M
$58.4M
Q4 24
$282.4M
$71.6M
Q3 24
$284.4M
$69.4M
Q2 24
$295.6M
$77.6M
Total Debt
MP
MP
XERS
XERS
Q1 26
$1.0B
Q4 25
$998.7M
$220.3M
Q3 25
$997.3M
$219.5M
Q2 25
$910.8M
$218.6M
Q1 25
$909.8M
$229.8M
Q4 24
$908.7M
$232.1M
Q3 24
$216.2M
Q2 24
$230.5M
Stockholders' Equity
MP
MP
XERS
XERS
Q1 26
$2.0B
Q4 25
$2.0B
$13.7M
Q3 25
$2.0B
$-861.0K
Q2 25
$1.0B
$-19.3M
Q1 25
$1.0B
$-35.1M
Q4 24
$1.1B
$-29.6M
Q3 24
$1.1B
$-28.3M
Q2 24
$1.1B
$-19.3M
Total Assets
MP
MP
XERS
XERS
Q1 26
$3.8B
Q4 25
$3.9B
$383.5M
Q3 25
$3.8B
$370.2M
Q2 25
$2.3B
$334.7M
Q1 25
$2.4B
$315.5M
Q4 24
$2.3B
$323.1M
Q3 24
$2.3B
$321.1M
Q2 24
$2.4B
$331.7M
Debt / Equity
MP
MP
XERS
XERS
Q1 26
0.51×
Q4 25
0.50×
16.10×
Q3 25
0.51×
Q2 25
0.90×
Q1 25
0.88×
Q4 24
0.86×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MP
MP
XERS
XERS
Operating Cash FlowLast quarter
$-1.9M
$20.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.81×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MP
MP
XERS
XERS
Q1 26
$-1.9M
Q4 25
$-46.9M
$20.0M
Q3 25
$-42.0M
$18.4M
Q2 25
$-3.7M
$182.0K
Q1 25
$-63.2M
$-10.0M
Q4 24
$30.5M
$2.0M
Q3 24
$-6.8M
$-8.3M
Q2 24
$30.8M
$-10.3M
Free Cash Flow
MP
MP
XERS
XERS
Q1 26
Q4 25
$-109.3M
Q3 25
$-92.5M
Q2 25
$-32.7M
Q1 25
$-93.7M
Q4 24
$-11.2M
Q3 24
$-53.3M
Q2 24
$-15.6M
FCF Margin
MP
MP
XERS
XERS
Q1 26
Q4 25
-207.4%
Q3 25
-172.8%
Q2 25
-56.9%
Q1 25
-154.0%
Q4 24
-18.3%
Q3 24
-84.7%
Q2 24
-50.1%
Capex Intensity
MP
MP
XERS
XERS
Q1 26
Q4 25
118.5%
Q3 25
94.3%
Q2 25
50.5%
Q1 25
50.1%
Q4 24
68.3%
Q3 24
73.8%
Q2 24
148.7%
Cash Conversion
MP
MP
XERS
XERS
Q1 26
Q4 25
-4.97×
1.81×
Q3 25
29.68×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MP
MP

Materials Segment$72.2M80%
Magnetics Segment$21.1M23%

XERS
XERS

Products$83.4M97%
Other$2.4M3%

Related Comparisons